Israel-based OncoHost closes $8M in Series B funding to provide personalized cancer therapy for more effective treatment
OncoHost, a Binyamina, Israel-based clinical-stage biotechnology startup company developing personalized strategies to increase the success of cancer therapy, today announced it has closed an $8 million Series B funding round to match the right treatment to an individual cancer patient, increasing the effectiveness […]